Bioethics, Quality Regulation and Case Reports

Bioethics is the study of the typically controversial ethical issues emerging from new situations and possibilities brought about by advances in medicine. It is also moral discernment as it relates to medical policy, practice, and research. Bioethicists are concerned with the ethical questions that arise in the relationships among life sciences, biotechnology, medicine, clinical research, and philosophy etc. One of the first areas addressed by modern bioethicists was that of human experimentation. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research was initially established in 1974 to identify the basic ethical principles that should underlie the conduct of biomedical and behavioral research involving human subjects.
 

Improvements in FDA review process efficiency and more frequent and timely interactions with FDA Overall; the therapeutic area with the highest clinical research burden across all phases is respiratory system ($115.3 million) followed by pain and anaesthesia ($105.4 million) and oncology ($78.6 million) trials. Use of lower-cost facilities/in-home testing and wider use of mobile technologies appear to be most effective in reducing costs across therapeutic areas and trial phases. Use of lower-cost facilities and/or in-home testing can reduce per-trial costs by up to $0.8 million (16 percent) in Phase 1, $4.3 million (22 percent) in Phase 2, and $9.1 million (17 percent) in Phase 3, depending on therapeutic area

 
Clinical research ethics are the set of relevant ethics considered in the conduct of a clinical trial in the field of clinical research. It borrows from the broader fields of research ethics and medical ethics. Quality of clinical trials depends on data integrity and subject protection. Globalization, outsourcing and increasing complexity of clinical trials have made the target of achieving global quality challenging. The quality, as judged by regulatory inspections of the investigator sites, sponsors/contract research organizations and Institutional Review Board, has been of concern to the US Food and Drug Administration, as there has been hardly any change in frequency and nature of common deficiencies. Good Clinical Practice (GCP) is the universal ethical and scientific quality standard for conducting clinical trials. The GCP standard applies to all aspects of the clinical trial process.

Clinical research ethics are the set of relevant ethics considered in the conduct of a clinical trial in the field of clinical research. It borrows from the broader fields of research ethics and medical ethics. Quality of clinical trials depends on data integrity and subject protection. Globalization, outsourcing and increasing complexity of clinical trials have made the target of achieving global quality challenging. The quality, as judged by regulatory inspections of the investigator sites, sponsors/contract research organizations and Institutional Review Board, has been of concern to the US Food and Drug Administration, as there has been hardly any change in frequency and nature of common deficiencies. Good Clinical Practice (GCP) is the universal ethical and scientific quality standard for conducting clinical trials. The GCP standard applies to all aspects of the clinical trial process

  • Compliance and regulatory requirements in clinical research
  • Ethical regulatory guidelines
  • Capacity building in clinical research
  • Bioethics: Case studies
  • Pharmacokinetics-Pharmacodynamics for regulatory decision
  • Ethical and regulatory issues

Related Conference of Bioethics, Quality Regulation and Case Reports

Sep 25-26, 2017

12th Annual
Pharma Middle East Congress

Dubai, UAE
October 02-03, 2017

9th Annual Pharmaceutical Chemical Analysis Congress

Vienna, Austria
October 05-06, 2017 Park Inn by Radisson London Heathrow,

5th International Conference and Exhibition on Pain Research and Management

London, UK
October 16-17, 2017

16th Annual Medicinal & Pharmaceutical Sciences Congress

Seoul, South Korea
October 16-18, 2017
(10 Plenary Forums - 1 Event)

4th International Conference on Past and Present Research Systems of Green Chemistry

Atlanta, Georgia, USA
October 18-19, 2017

6th Global Congress on Mass Spectrometry

Osaka, Japan
October 19-20, 2017

9th Annual Congress on Drug Design & Drug Formulation

Seoul, South Korea
October 19-20, 2017

4th International Conference and Exhibition on Pain Medicine

(10 Plenary Forums - 1 Event)
San Francisco, California, USA
October 30-November 01, 2017
A B2B Networking & Global Knowledge Exchange Forum

Annual Congress on Emerging Orphan Drugs and  Rare Diseases

San Antonio, Texas, USA
November 13-14, 2017

Global Experts Meeting on Toxicology

Singapore
March 19-20, 2018

International Meeting on Nutraceuticals

Singapore
March 26-27, 2018

World Congress on Herbal and Chinese Medicine

Bali, Indonesia
April 20-21, 2018

4th International Conference on Antibiotics

Las Vegas, Nevada, USA
April 26-27, 2018

11th European Biosimilars Congress

Rome, Italy
May 07-09, 2018

10th Annual European Pharma Congress

Frankfurt, Germany
June 18-19, 2018

9th Global Experts Meeting on Neuropharmacology

Paris, France
June 20-22, 2018

7th World Congress on Mass Spectrometry

Rome, Italy
July 09- 10, 2018

Annual Meeting on Pharmacology

Bangkok, Thailand
July 09-10, 2018

12th Global
Pharmacovigilance & Clinical Trials Summit

Sydney, Australia
July 16-18, 2018

15th Asia-Pacific Pharma Congress

Melbourne, Australia
Jul 30-Aug 01, 2018

10th World Congress on Pharmacology

Barcelona, Spain
August 13-14, 2018

Global Experts Meeting on Case Reports

Tokyo, Japan
September 13-14, 2018

8th World Congress on Chromatography

Prague, Czech Republic
September 24-25, 2018

7th International Conference on Clinical Trials

Chicago, USA
(10 Plenary Forums - 1 Event)
Oct 29-30, 2018

3rd Global Pharma Congress

Osaka, Japan

Bioethics, Quality Regulation and Case Reports Conference Speakers

Recommended Sessions

Related Journals

Are you interested in